Zydus Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ZYDUS, and what generic alternatives to ZYDUS drugs are available?
ZYDUS has three hundred and sixty-four approved drugs.
There is one US patent protecting ZYDUS drugs. There are twenty-five tentative approvals on ZYDUS drugs.
There are four patent family members on ZYDUS drugs in four countries and nine hundred and seven supplementary protection certificates in eighteen countries.
Summary for Zydus
| International Patents: | 4 |
| US Patents: | 1 |
| Tradenames: | 295 |
| Ingredients: | 286 |
| NDAs: | 364 |
| Patent Litigation for Zydus: | See patent lawsuits for Zydus |
Drugs and US Patents for Zydus
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zydus Pharms Usa Inc | CARVEDILOL | carvedilol | TABLET;ORAL | 077614-002 | Sep 5, 2007 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Zydus | CHLORPROMAZINE HYDROCHLORIDE | chlorpromazine hydrochloride | TABLET;ORAL | 213368-001 | Jan 17, 2020 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Zydus | VARENICLINE TARTRATE | varenicline tartrate | TABLET;ORAL | 216723-001 | Jun 12, 2023 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for ZYDUS drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | for Injection | 200 mcg/vial | ➤ Subscribe | 2015-05-01 |
| ➤ Subscribe | for Injection | 100 mcg/vial and 500 mcg/vial | ➤ Subscribe | 2015-04-14 |
| ➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
International Patents for Zydus Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Africa | 201606075 | ⤷ Try a Trial |
| Philippines | 12016501686 | ⤷ Try a Trial |
| World Intellectual Property Organization (WIPO) | 2015128877 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Zydus Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2443246 | 2021C/538 | Belgium | ⤷ Try a Trial | PRODUCT NAME: VAZKEPA - ICOSAPENT ETHYL; AUTHORISATION NUMBER AND DATE: EU/1/20/1524 20210329 |
| 0281459 | 9890035 | Sweden | ⤷ Try a Trial | PRODUCT NAME: PLAVIX-CLOPIDOGREL; REG. NO/DATE: EU/1/98/069/001 19980715 |
| 0764174 | C300159 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: COLESEVELAM, DESGEWENST IN DE VORM VAN EEN; REGISTRATION NO/DATE: EU/1/03/268/001 20040310 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
